Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
The Future of Tumor Markers: Advancing Early Malignancy Detection Through Omics Technologies, Continuous Monitoring, and Personalized Reference Intervals
Biomolecules
July 2025
Savas I.N.
Open Access
An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance
Metabolism Clinical and Experimental
January 2025
Armandi A.
Open Access
The Predictive Role of Osteopontin Level in Patients with Type 2 Diabetes Mellitus without Fatty Liver Disease
Journal of the Faculty of Medicine Baghdad
1 April 2024
Kadhum Q.K.
Open Access
Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis
Biomedicines
July 2023
Omar M.A.
Open Access
A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma
Frontiers in Oncology
2023
Yang T.
Open Access
Hepatocellular Carcinoma: Diagnosis, Molecular Pathogenesis, Biomarkers, and Conventional Therapy
Nanotherapeutics for the Treatment of Hepatocellular Carcinoma
1 January 2022
Mukherjee B.
Performance of SPINK1 and SPINK1-based diagnostic model in detection of hepatocellular carcinoma
Journal of Clinical Laboratory Analysis
November 2021
Wang F.
Open Access
Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
Cochrane Database of Systematic Reviews
15 April 2021
Colli A.
All Open Access, Green
Serum osteopontin predicts glycaemic profile improvement in metabolic syndrome: A pilot study
European Journal of Clinical Investigation
March 2021
Caserza L.
Proteomic profiling and artificial intelligence for hepatocellular carcinoma translational medicine
Biomedicines
February 2021
Moldogazieva N.T.
Open Access
The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis
Plos One
1 February 2020
Zhang J.
Open Access
Role of annexin A2 and osteopontin for early diagnosis of hepatocellular carcinoma in hepatitis C virus patients
Egyptian Liver Journal
1 December 2019
Hanno A.E.F.F.
Open Access
Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus
Journal of Investigative Medicine
1 March 2019
Sobhy A.
Evaluation of click chemistry microarrays for immunosensing
Beilstein Journal of Nanotechnology
2019
Dadfar S.M.M.
Open Access
Molecular diagnosis of hepatocellular carcinoma: trends in biomarkers combination to enhance early cancer detection
Hepatoma Research
2019
Chia T.S.
Open Access
Biomarkers in diagnosis and prediction of hepatocellular carcinoma recurrence
Sovremennye Tehnologii V Medicine
2019
Malov S.I.
Open Access
Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma
Royal Society Open Science
1 December 2018
Menyhárt O.
Open Access
Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: A meta-analysis
Oncotargets and Therapy
2018
Sun T.
Open Access
Discovery of a potential plasma protein biomarker panel for acute-on-chronic liver failure induced by hepatitis B virus
Frontiers in Physiology
6 December 2017
Zhou N.
Open Access
Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up
Cytokine
November 2017
Cabiati M.
All Open Access, Green
Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis
Clinics and Research in Hepatology and Gastroenterology
October 2017
Li J.
Suppression of osteopontin inhibits chemically induced hepatic carcinogenesis by induction of apoptosis in mice
Oncotarget
2016
Lee S.H.
Open Access